This report looks at the highly anticipated hepatitis C drug sofosbuvir, and how it is priced out of reach for those who need it most.
Sign up to receive updates about our work in Health.
Despite advances in medical science, affordable safe and effective medicines remain inaccessible to billions of people worldwide. The Open Society Foundations support efforts to increase access to essential medicines for people in low-resource countries, especially for poor and marginalized populations.
The following Open Society programs focus on this topic.
This report examines the impact the Global Fund’s withdrawal from middle-income countries may have on key populations, and highlights the need for increased funding of human rights–related programs.
The lack of drugs to cure or prevent Ebola shows that the private drug development is not meeting public health needs. Luckily, a new public model is emerging.
Two of South Africa’s most recognized legal activists talk about using the law to campaign for the human rights of people living with HIV.
What’s really driving the pharmaceutical giant Gilead to issue a license for generic copies of its superstar drug? Profit.
Inna Pidluska of Ukraine’s International Renaissance Foundation discusses Ukraine’s evolving political culture, early elections, and potential opportunities for civil society and parliamentarians to pursue a reform agenda.
A film about a heroin-assisted treatment program in Denmark addresses the evidence behind prescribing heroin to people with long-term opioid dependency.